Skip to main content
Endobarrier improves health outcomes in diabetes, study finds
9/19/2017

Type 2 diabetes patients with refractory obesity had significant reductions in A1C levels, mean body mass index, insulin use, systolic blood pressure and weight one year after using the Endobarrier, a temporary duodenal-jejunal sleeve not currently available in the US, according to a study presented at the European Association for the Study of Diabetes' annual meeting. UK researchers used a cohort of 65 patients and found that 11 of 17 patients sustained these improvements six months after removal of the device.

Full Story: